BIO vs PG · rev $2.58B vs P/E 25, rev $84.28B
BIO (BIO) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
BIO currently screens at market cap $0. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the BIO and PG stock pages for the full models.
Not investment advice.